Week 3 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

GENERAL CHARACTERISTICS Haemophilus

A
  • Gram-negative
  • Pleomorphic small bacilli - sometimes almost coccal in shape, sometimes as short filaments
  • Non-motile, do not form spores
  • Encapsulated (typeable) or non-encapsulated (non-typeable)
  • aerobic, facultatively anaerobic - generate energy for growth either oxidatively (preferred) or fermentatively
  • oxidase positive
  • Most species have fastidious nutritional requirements e.g.
  • Factor X (haemin) and/or
  • Factor V (nicotine adenine dinucleotide)
  • optimal growth at 35oC to 37oC in humid atmosphere containing 5% to 10% CO2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NATURAL HABITAT Haemophilus

A
  • Most non-encapsulated Haemophilus species are normal inhabitants of the
    upper respiratory tract of humans and other animals
  • 85% of adults harbour these organisms as part of normal bacterial flora in nasopharynx and oropharynx
  • Encapsulated H. influenzae may also be found as part of the normal upper respiratory tract flora of both children and adults
  • Colonisation by H. influenzae capsular serotype b strains is uncommon in healthy infants (0.7%), children (3% to 5%), rare in adults
  • But most infections are caused by H. influenzae capsular serotype b
  • Haemophilus ducreyi is a pathogen of the genital tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

VIRULENCE FACTORS Haemophilus

A
  • Capsule − major antigenic determinant of encapsulated H. influenzae - capsular polysaccharide
    −this polysaccharide confers type specificity on the organism, the basis for grouping of organism into 6 serotypes (a, b, c, d, e, f)
    −strains associated with invasive disease belong to serotype b

serotype b capsular polymer unique:
* contains pentose sugars (e.g., ribose) and ribitol-phosphate (polyribosilribitol-phosphate - PRP, inhibits phagocytosis and intracellular killing by neutrophils)
* instead of hexoses or hexosamines as found in other serotypes

  • Pili
  • IgA1 protease
  • Adhesins
  • Bacteriocin - haemocin
    − protein able to inhibit growth of strains of same or related species (for competition)
  • Outer Membrane Proteins (OMPs)
    − responsible for attachment, invasiveness, resistance to phagocytosis
  • Lipooligosaccharide (LOS)
    − outer membrane component that exerts paralysing action on ciliated respiratory epithelium
    − promotes proliferation of organisms in bronchial tree
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CLINICAL SIGNIFICANCE - HAEMOPHILUS INFLUENZAE

A
  • world-wide in distribution, endemic in nature
  • infection occurs after inhalation of infected droplets from:
    −clinically active cases
    −convalescent patients
    −carriers

MENINGITIS
* most cases in infants and children younger than age of 6 years
* more than 90% of isolates belong to capsular serotype b
* clinically resembles meningococcal meningitis
* complications unusual, may include:
− brain abscess
− pericarditis
−abscess formation at other body sites
* in adults, usually complicates underlying diseases or conditions including:
− head trauma
−chronic sinusitis, otitis media
− diabetes, chronic alcoholism
−tracheobronchitis, pneumonia
−immunodeficiency states

OTITIS MEDIA
* only 10% of isolates are serotype b
* symptoms include ear pain with or without ear drainage

SINUSITIS
* causes 20% to 40% of acute sinusitis in children and adults
* usually a secondary invader following a viral sinus infection
* most isolates are non-encapsulated

EPIGLOTTITIS
* typically in children between 2 and 7 years of age
* most common cause is serotype b
* infection acute, with abrupt onset of obstructive laryngeal oedema

UPPER AND LOWER RESPIRATORY TRACT INFECTIONS
* causes acute pharyngitis and laryngitis
* pre-existing viral infection usually present
* chronic bronchitis, acute exacerbations of purulent bronchitis, acute febrile tracheobronchitis caused by non-encapsulated strains
* pneumonia

BACTERAEMIA AND ENDOCARDITIS
* usually accompanied by:
− cellulitis
− arthritis
− osteomyelitis

UROGENITAL, MATERNAL, AND PERINATAL INFECTIONS* non-encapsulated strains cause:
− urethritis
−tubo-ovarian abscesses
−septic abortion
− postpartum bacteraemia
− neonatal sepsis with and without meningitis

CONJUNCTIVITIS
* causes contagious, acute conjunctivitis - “pinkeye”

BRAZILIAN PURPURIC FEVER
* caused by a single clone of Haemophilus influenzae biogroup aegyptius
* acute illness characterised by:
− high fever
− abdominal pain
− vomiting
− purpuric rash
− eventually vascular collapse, hypotensive shock, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CLINICAL SIGNIFICANCE - HAEMOPHILUS PARAINFLUENZAE

A
  • causes endocarditis
  • higher incidence of vegetations on heart valves and septic complications
    resulting from embolisation of these vegetations to large arteries
  • may cause secondary bacteraemia and urethritis in adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CLINICAL SIGNIFICANCE - OTHER HAEMOPHILUS SPP. (not H. Influenzae or parainfluenzae)

A
  • Aggregatibacter aphrophilus and Haemophilus paraphrophilus
    −cause endocarditis and brain abscess
    − may cause: pneumonia, meningitis, secondary bacteraemia

other species are rarely associated with infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLINICAL SIGNIFICANCE - HAEMOPHILUS DUCREYI

A
  • causes chancroid, highly contagious, sexually transmitted infection* manifested by shallow genital ulcerations (sharply circumscribed, nonindurated, painful ulcers - “soft chancres”)
  • may be accompanied by inguinal lymphadenopathy (suppurative buboes develop in ½ of patients)
  • world-wide in distribution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS Haemophilus

A
  • specimen collected depends on the area of involvement:
    − blood
    − other body fluids (CSF, synovial fluid, pericardial fluid, pleural fluid)
    − middle ear aspirates, middle ear drainage fluid
    − sinus aspirates, upper respiratory tract material
    − sputum, bronchoalveolar lavage
    − purulent ocular discharge
    − material collected from exposed base or margin of genital lesion
  • Stuart’s or Amies Transport Medium adequately maintains organisms’ viability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CULTURE MEDIA Haemophilus

A

Selective media
* Haemophilus isolation agar medium
* Mueller-Hinton base chocolate agar medium supplemented with 1% IsoVitaleX(BBL Microbiology Systems) and 3µg/mL vancomycin
−adequately supports growth of Haemophilus ducreyi

Non-selective media
* Chocolate agar medium
−supplies factors necessary for growth of most Haemophilus spp.:
* haemin or haematin (X factor)
* nicotine adenine dinucleotide - NAD or NAD phosphate -NADP (V factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

INCUBATION CONDITIONS Haemophilus

A
  • 35oC to 37oC
  • from 24 hours to 72 hours
  • up to 7 days for Haemophilus ducreyi
  • in 5% to 10% CO2
    -enriched atmosphere
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DIRECT EXAMINATION Haemophilus

A
  • detection of specific polysaccharide capsular antigens in body fluids

DNA probe assays
* PCR-based

  • Haemolytic reaction on horse blood agar
  • Growth requirements for X and V factors
  • MALDI-TOF MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SEROLOGIC TESTS Haemophilus

A
  • Serotyping methods
    − relevant only for encapsulated (typeable) strains of Haemophilus influenzae
    − agglutination of organisms in type-specific antisera
  • Detection of antibodies to Haemophilus spp.
    − Enzyme Immunoassays (EIA) for Haemophilus ducreyi IgG and IgM antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ANTIBIOTIC SUSCEPTIBILITIES Haemophilus

A
  • recommended initial therapy for meningitis:
    combination of ampicillin and chloramphenicol
  • ceftriaxone or cefotaxime alternative therapy
  • treatment for chancroid: erythromycin or ceftriaxone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IMMUNISATION Haemophilus

A

Active immunisation
* availability of safe and effective vaccines against Haemophilus influenzaeserotype b altered incidence of serious infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GENERAL CHARACTERISTICS Pasteurella

A
  • Gram-negative coccobacilli or rods, show bipolar staining, no special arrangement (present singly, in pairs, short chains or small groups)
  • non-motile, do not form spores
  • facultatively anaerobic
  • oxidase positive, catalase positive, fermentative
  • reduce nitrate to nitrite
  • virulent organisms produce a capsule
  • generally susceptible to β-lactam antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CLINICAL SIGNIFICANCE Pasteurella

A

Infection via bites or scratches
* Pasteurella multocida recovered from ½ of infected animal bites* symptoms include:
−rapid development of pain
−erythema
−swelling
− purulent or serosanguineous drainage at site of wound

  • complications include:
    − pyarthrosis
    − necrotising synovitis
    − osteomyelitis of underlying bone
    − regional lymphadenitis

Infection of lung in patients with pre-existing chronic pulmonary disease
* patients middle-aged or older
* upper respiratory tract diseases associated with recovery of Pasteurella multocida:
−sinusitis, mastoiditis
−chronic otitis media
* lower respiratory tract diseases associated with recovery of Pasteurella multocida:
− bronchiectasis, bronchogenic carcinoma
−chronic bronchitis, emphysema
− pulmonary abscess, pneumonia

17
Q

COLLECTION, TRANSPORT AND STORAGE OF SPECIMENS Pasteurella

A
  • specimen depends on area of involvement:
    − purulent exudate from animal bites
    − nasal swabs
    −early morning sputum
    − bronchial washing
    −spinal fluid
    − blood
18
Q

CULTURE MEDIA AND INCUBATION CONDITIONS Pasteurella

A

Non-selective media
* 5% sheep blood agar medium
* Chocolate agar medium
* 35oC to 37oC
* for 24 hours
* in CO2
-enriched atmosphere

19
Q

ISOLATION PROCEDURES - PASTEURELLA MULTOCIDA

A
  • grows well on routinely inoculated laboratory media (5% sheep blood agar medium, chocolate agar medium)
  • does not grow on MacConkey agar, other selective or differential enteric media
  • colonies non-haemolytic, small, translucent, may be smooth or rough
  • brown discoloration of medium may develop around colonies
  • on blood agar medium “mushroom” smell
  • isolates from respiratory tract specimens may be mucoid
20
Q

IDENTIFICATION

A
  • Colony morphology
  • Gram stain of colony
  • Oxidase Test
  • Catalase Test
  • MALDI-TOF MS
  • PCR assay for direct detection of organisms
21
Q

ANTIBIOTIC SUSCEPTIBILITIES AND IMMUNISATION Pasteurella

A
  • recommended therapy: penicillins
  • cephalosporins, tetracycline, chloramphenicol - effective